SUMO modifies GβL and mediates mTOR signaling

Sophia Louise Lucille Park1, Uri Nimrod Ramírez-Jarquín1, Neelam Shahani1

  • 1Department of Neuroscience, The Wertheim UF Scripps Institute, Jupiter, Florida, USA.

PubMed

Insights

Small ubiquitin-like modifier (SUMO) attaches to G protein β-subunit-like protein (GβL), impacting mechanistic target of rapamycin (mTOR) complex assembly and signaling. This SUMOylation is crucial for nutrient-induced mTOR pathway activation.

Area of Science:

  • Cellular signaling pathways
  • Post-translational modifications
  • Protein complex assembly

Background:

  • Mechanistic target of rapamycin (mTOR) signaling is vital for cell growth and metabolism.
  • mTOR regulation involves numerous proteins and post-translational modifications, but mechanisms are not fully understood.
  • Small ubiquitin-like modifier (SUMO) is a key post-translational modification influencing protein function.

Purpose of the Study:

  • To investigate the role of SUMOylation in the assembly and activity of mTOR complexes.
  • To identify which mTOR components are SUMOylated and the specific sites of modification.

Main Methods:

  • Investigated SUMOylation status of core mTOR components using biochemical assays.
  • Identified SUMOylation sites on GβL (mLST8) using mutagenesis and mass spectrometry.
  • Assessed the impact of SUMO depletion and GβL SUMOylation mutants on mTOR complex formation and signaling.

Main Results:

  • The regulatory subunit GβL (mLST8) is SUMOylated by SUMO1, 2, and 3 isoforms at multiple lysine residues (K86, K215, K245, K261, K305).
  • SUMOylation of GβL is essential for the formation of mTOR-Raptor and mTOR-Rictor complexes.
  • Depletion of SUMO or use of SUMOylation-defective GβL mutants impairs nutrient-induced mTOR signaling.

Conclusions:

  • This study reveals a novel role for SUMOylation in regulating mTOR signaling.
  • SUMOylation of GβL is critical for the proper assembly of mTOR complexes (mTORC1 and mTORC2).
  • SUMO modification of GβL directly influences mTOR pathway activity and nutrient sensing.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.9K